Savvy buys bolster this Power pick’s growth

Article Excerpt

We think the healthcare industry will enjoy great success over the next decade. But due to the nature of the business, results will vary widely and unpredictably from one company to another. A volatile market like the one we expect for healthcare stocks will include winners and losers. Here is one that we expect to be among the big winners. Thermo Fisher’s shares are now up 74.0% for our subscribers since we first recommended the stock in the May 2020 issue of Power Growth Investor at $325.83 a share. We still think it has room to move higher. It’s a Power Buy. THERMO FISHER SCIENTIFIC INC., $566.83, is a buy. Your shares (New York symbol TMO; TSINetwork Rating: Average) (www.thermofisher.com; Shares outstanding: 391.8 million; Market cap: $222.1 billion; Dividend yield: 0.2%) let you tap this leading manufacturer of scientific instruments, laboratory equipment, diagnostic consumables, and life science reagent chemicals. In the quarter ended December 31, 2022, Thermo Fisher’s revenue rose 7.0%, to $11.45 billion from $10.70 billion a year…